Cas:816429-58-0 (s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane manufacturer & supplier

Chemical Name:(s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane

CAS.NO:816429-58-0

Synonyms:(s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane

Molecular Formula:C₁₄H₂₀N₂

Molecular Weight:216.32200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:334ºC at 760 mmHg

Density:1.08g/cm3

Index of Refraction:1.588

PSA:15.27000

Exact Mass:216.16300

LogP:1.93200

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane Use and application,(s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane technical grade,usp/ep/jp grade.

Related News: After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. (s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane manufacturer The rest of South Korea will also consider stopping issuing tourist visas to Chinese nationals, said Park Neung-hoo, the government��s minister of health and welfare. All travelers from China will be separated from the other arrivals for heightened screening at airports. (s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane supplier By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names. (s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane vendor From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity. (s,s)-3-benzyl-1,4-diazabicyclo[4.3.0]nonane factory After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.